Avior Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-60
Closed -$24.8K 1488
2024
Q4
$24.8K Buy
60
+5
+9% +$2.19K ﹤0.01% 1361
2024
Q3
$27.8K Sell
55
-2
-4% -$972 ﹤0.01% 1303
2024
Q2
$27.8K Sell
57
-131
-70% -$65.8K ﹤0.01% 1276
2024
Q1
$102K Buy
188
+178
+1,780% +$97.3K ﹤0.01% 954
2023
Q4
$5.55K Hold
10
﹤0.01% 1117
2023
Q3
$4.37K Hold
10
﹤0.01% 1231
2023
Q2
$5.02K Hold
10
﹤0.01% 1164
2023
Q1
$5K Buy
+10
New +$4.79K ﹤0.01% 1201
2021
Q3
Sell
-3
Closed -$1K 1114
2021
Q2
$1K Hold
3
﹤0.01% 969
2021
Q1
$1K Hold
3
﹤0.01% 953
2020
Q4
$1K Buy
+3
New +$1.34K ﹤0.01% 921

Other funds holding IDXX

Avior Wealth Management's IDXX Position: Q1 2025 in Review

Avior Wealth Management sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 60 shares — an estimated $24.8K sold.

Avior Wealth Management first reported a position in IDXX in Q4 2020 and held it in 11 quarters. The position peaked at $102K in Q1 2024. 1,144 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Avior Wealth Management reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 60 Idexx Laboratories shares in Q1 2025, an estimated $24.8K.
  • Avior Wealth Management first reported a position in Idexx Laboratories in Q4 2020 and held it in 11 quarters.
  • Avior Wealth Management's Idexx Laboratories position peaked at $102K in Q1 2024.
  • 1,144 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.